InvestorsHub Logo

art2426

04/15/20 4:18 PM

#223219 RE: 4toSchool #223215

Actipatch is a 10 year disappointed to me. That was the reason I made my first investment in this company. I thought it would be a 'potential' BIG seller. There's that word again! This company has a boatload of 'POTENTIAL' big selling products. Problem is they have no idea HOW to sell them. They have a guy willing to do it, but he seems to be on a very short leash. Great products, CRAP leadership. Maybe they will let him go sell the products when they (IBEX) are done loaning money to company for 1/2 price shares. GET MUCH MORE stock for those loans when the stock price is low!!!

markjohn62

04/15/20 4:56 PM

#223222 RE: 4toSchool #223215

This was on the Bioelectronics shareholders Facebook page.


Kelly Whelan As of 3/13- "The data file has finally been put together. However, the statistician believes he won't get to it until the first week of April. However, I have asked them to release the data file to us, we had agreed on this previously but the data does belong to them. So with luck we should have the data next week or so, but of course we don't know yet if it will be successful and can be used for an FDA market clearance application." - Ian Rawe, Ph.D., BioElectronics


av8tor65

04/15/20 5:08 PM

#223223 RE: 4toSchool #223215

4to...they are waiting for the Principal Investigator to compile the data...evidently they are swamped...seems like there is always something gumming up the works.

GL